McKesson Corporation (MCK) Stock Analysis
Recovery setup
Healthcare · Medical Distribution
Sell if holding. Engine safety override at $779.61: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.5/10. Specifically: Elevated put/call ratio: 1.43; Below-average business quality; Below long-term trend.
McKesson is a diversified healthcare services company with four segments—North American Pharmaceutical distribution, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions—serving pharmacies, hospitals, and providers across North America.... Read more
Sell if holding. Engine safety override at $779.61: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.5/10. Specifically: Elevated put/call ratio: 1.43; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 58. Score 5.5/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-06-14Recent Developments — McKesson Corporation
Latest news
- NEWS Barclays Maintains Overweight on McKesson, Lowers Price Target to $925 — benzinga Jun 10, 2026 neutral
- NEWS Here's How Much $100 Invested In McKesson 20 Years Ago Would Be Worth Today — benzinga Jun 8, 2026 positive
- NEWS Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch — benzinga Jun 3, 2026 positive
- NEWS McKesson Announces Completion Of Previously-Announced $1.25B Minority Ownership Investment By Apollo Funds For 13% Of MC — benzinga Jun 2, 2026 positive
- NEWS $1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today — benzinga May 25, 2026 positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-04-28Item 1.02MEDIUMMcKesson terminated its existing $1.0B 364-day and $4.0B five-year revolving credit facilities on April 24, 2026, replacing them with a new consolidated $5B revolving credit facility. Successor agreement in place.SEC filing →
- 2026-03-05Item 5.02MEDIUMCFO Britt J. Vitalone gave notice of retirement; last day as CFO May 28, 2026. Kenny K. Cheung (former CFO of Sysco) appointed new CFO effective May 29, 2026. Clean handoff.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $779.61: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.5/10. Specifically: Elevated put/call ratio: 1.43; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 58. Prior stop was $750.33. Score 5.5/10, moderate confidence.
Take-profit target: $847.26 (+8.1% upside). Prior stop was $750.33. Stop-loss: $750.33.
Quality below floor (3.5 < 4.0).
McKesson Corporation trades at a P/E of 20.4 (forward 15.6). TrendMatrix value score: 6.4/10. Verdict: Sell.
23 analysts cover MCK with a consensus score of 4.3/5. Average price target: $941.
What does McKesson Corporation do?McKesson is a diversified healthcare services company with four segments—North American Pharmaceutical distribution,...
McKesson is a diversified healthcare services company with four segments—North American Pharmaceutical distribution, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions—serving pharmacies, hospitals, and providers across North America. With 43,000+ employees and 27 U.S. pharmaceutical distribution centers, it has announced plans to separate its Medical-Surgical segment.